BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28791406)

  • 21. Loss of miR-1258 contributes to carcinogenesis and progression of liver cancer through targeting CDC28 protein kinase regulatory subunit 1B.
    Hu M; Wang M; Lu H; Wang X; Fang X; Wang J; Ma C; Chen X; Xia H
    Oncotarget; 2016 Jul; 7(28):43419-43431. PubMed ID: 27270326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion.
    Jiang J; Liu Z; Ge C; Chen C; Zhao F; Li H; Chen T; Yao M; Li J
    J Biol Chem; 2017 Nov; 292(47):19146-19159. PubMed ID: 28972178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
    Zhu M; Li M; Wang T; Linghu E; Wu B
    Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
    Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
    Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway.
    Gu W; Li X; Wang J
    Oncol Rep; 2014 Jan; 31(1):397-404. PubMed ID: 24190507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-199 suppresses cell proliferation, migration and invasion by downregulating RGS17 in hepatocellular carcinoma.
    Zhang W; Qian S; Yang G; Zhu L; Zhou B; Wang J; Liu R; Yan Z; Qu X
    Gene; 2018 Jun; 659():22-28. PubMed ID: 29559347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gα12gep oncogene inhibits FOXO1 in hepatocellular carcinoma as a consequence of miR-135b and miR-194 dysregulation.
    Jung HS; Seo YR; Yang YM; Koo JH; An J; Lee SJ; Kim KM; Kim SG
    Cell Signal; 2014 Jul; 26(7):1456-65. PubMed ID: 24631529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.
    Huang GH; Shan H; Li D; Zhou B; Pang PF
    Cell Biochem Funct; 2017 Mar; 35(2):98-104. PubMed ID: 28261837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of tumorigenesis and metastasis of hepatocellular carcinoma tumor endothelial cells by microRNA-3178 and underlying mechanism.
    Li W; Shen S; Wu S; Chen Z; Hu C; Yan R
    Biochem Biophys Res Commun; 2015 Aug; 464(3):881-7. PubMed ID: 26182877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1.
    Liu DZ; Chang B; Li XD; Zhang QH; Zou YH
    Clin Transl Oncol; 2017 Sep; 19(9):1133-1140. PubMed ID: 28397066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of microRNA‑660 inhibits cell proliferation and invasion in osteosarcoma by directly targeting forkhead box O1.
    Zhang P; Gao H; Li Q; Chen X; Wu X
    Mol Med Rep; 2018 Aug; 18(2):2433-2440. PubMed ID: 29901128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
    Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-411 contributes the cell proliferation of lung cancer by targeting FOXO1.
    Zhao Z; Qin L; Li S
    Tumour Biol; 2016 Apr; 37(4):5551-60. PubMed ID: 26572153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-224 promotion of cell migration and invasion by targeting Homeobox D 10 gene in human hepatocellular carcinoma.
    Li Q; Ding C; Chen C; Zhang Z; Xiao H; Xie F; Lei L; Chen Y; Mao B; Jiang M; Li J; Wang D; Wang G
    J Gastroenterol Hepatol; 2014 Apr; 29(4):835-42. PubMed ID: 24219032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of miR-377 contributes to IRX3 deregulation in hepatocellular carcinoma.
    Wang P; Zhuang C; Huang D; Xu K
    Oncol Rep; 2016 Jul; 36(1):247-52. PubMed ID: 27222047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
    Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W
    BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
    Wang K; Liang Q; Wei L; Zhang W; Zhu P
    Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.
    Zhao J; Xu T; Wang F; Cai W; Chen L
    Biomed Pharmacother; 2017 Jun; 90():744-751. PubMed ID: 28419971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.